Biopharma Group champions precision and sterility in aseptic fill-finish with cutting-edge solutions

Increased demand for injectable drugs and stricter regulations drive surge in aseptic fill-finish technology, with Biopharma Group emerging as a trusted partner for UK and Irish pharma companies.

Why is aseptic fill-finish critical? The number one reason for people to incorporate aseptic fill-finish lines into their pharma production is that both the equipment and process, safeguard the efficacy, integrity, and ultimately, the safety of sterile medications. With the UK and Ireland's aseptic fill-finish market currently projected to reach £3.8 billion, Biopharma Group understands the importance of:

• Precision: Choosing the right equipment for accurate dosing and sterility is paramount

• Compliance: Modern systems prioritise validated cleaning, data integrity, and container closure integrity testing (CCIT)

• Safety: Integrated cleanroom environments, advanced sterilisation technologies, and automated inspection systems minimise contamination risks

Case Study: Using aseptic fill-finish solutions from Biopharma Group, a leading pharmaceutical company reduced waste, increased efficiency, and improved product quality. The results following installation were very impressive:

• 50% reduction in waste product

• 20% increase in production efficiency

• 30% reduction in downtime

• Significant improvement in product quality observed

• Clear return on investment

By collaborating with ATS Scientific Life Sciences and Comecer, Biopharma Group offers a comprehensive equipment range to the UK & Irish markets. Combined with Biopharma Group’s 35+ years of expertise in the freeze drying and pharma fields, the solutions for those needing aseptic processing are comprehensive, including: 

• Aseptic fill-finish equipment: Isolators, RABS, filling lines, inspection systems
• Freeze dryers and lyo services: Biopharma Group has advanced freeze dryers that are configurable to your needs, validated processes, and CDMO services with dedicated lyo R&D to manufacturing, low bio-burden, and cyto labs.
• Technical support and training: From purchase to installation and for the lifetime of your equipment, you’ll receive support throughout the process.

Contact Biopharma Group today to discuss your requirements.

Elevate your injectable drug production with Biopharma Group's commitment to precision and sterility in aseptic fill-finish.